Abstract: A low-power wireless communication device is in a sleep or standby mode of operation for extended periods of time, periodically becoming fully operational and issuing a “check in” message to a base station, thereby inhibiting the ability of the base station to assist in the locating of device, and remotely updating the settings or operational programming of the device much of the time. Upon receipt of a command to locate a misplaced low-power wireless device or to update the device, a base station queues an associated command in a task queue. Upon receipt of a check-in message from an associated low-power wireless device, indicating it is in a fully powered and communicative state of operation, the base station searches its task queue for applicable commands relative to the specific wireless device and executes them via communication with the now fully-operational wireless device.

Abstract: A low-power wireless communication device is in a sleep or standby mode of operation for extended periods of time, periodically becoming fully operational and issuing a “check in” message to a base station, thereby inhibiting the ability of the base station to assist in the locating of device, and remotely updating the settings or operational programming of the device much of the time. Upon receipt of a command to locate a misplaced low-power wireless device or to update the device, a base station queues an associated command in a task queue. Upon receipt of a check-in message from an associated low-power wireless device, indicating it is in a fully powered and communicative state of operation, the base station searches its task queue for applicable commands relative to the specific wireless device and executes them via communication with the now fully-operational wireless device.

Abstract: Methods and systems for stabilizing a resonant modulator include receiving pre-modulation and post-modulation portions of a carrier signal, determining the average power from these portions, comparing an average input power to the average output power, and operating a heater coupled to the modulator based on the comparison. One system includes a pair of input structures, one or more processing elements, a comparator, and a control element. The input structures are configured to extract pre-modulation and post-modulation portions of a carrier signal. The processing elements are configured to determine average powers from the extracted portions. The comparator is configured to compare the average input power and the average output power. The control element operates a heater coupled to the modulator based on the comparison.

Abstract: The present invention relates to nutritional compositions intended to prevent or treat regurgitations in infants and young children without altering, or even improving their gut motility and/or for preventing and/or treating intestinal disorders of the infant or of the child. The invention also concerns the process for manufacturing this composition.

Abstract: The present invention relates to antibodies or fragments thereof that bind to TL1A. More specifically, the present invention relates to an antibody or fragment thereof that binds to TL1A comprising a heavy chain CDR1 comprising the amino acid sequence of SEQ ID NO: 51, and/or a heavy chain CDR2 comprising the amino acid sequence of SEQ ID NO: 52, and/or a heavy chain CDR3 comprising the amino acid sequence of SEQ ID NO: 53; and/or comprising a light chain CDR1 comprising the amino acid sequence of SEQ ID NO: 54, and/or a light chain CDR2 comprising the amino acid sequence of SEQ ID NO: 55 and/or a light chain CDR3 comprising the amino acid sequence of SEQ ID NO: 56.

Abstract: The invention relates to compositions intended for reducing, ideally for eliminating, regurgitation and/or gastro-oesophageal reflux phenomena affecting a subject. Anti-regurgitation and/or anti-reflux infant formulas and milks intended for feeding newborn babies, infants and young children are more particularly described.

Abstract: A low-power wireless communication device is in a sleep or standby mode of operation for extended periods of time, periodically becoming fully operational and issuing a “check in” message to a base station, thereby inhibiting the ability of the base station to assist in the locating of device, and remotely updating the settings or operational programming of the device much of the time. Upon receipt of a command to locate a misplaced low-power wireless device or to update the device, a base station queues an associated command in a task queue. Upon receipt of a check-in message from an associated low-power wireless device, indicating it is in a fully powered and communicative state of operation, the base station searches its task queue for applicable commands relative to the specific wireless device and executes them via communication with the now fully-operational wireless device.

Abstract: The various technologies presented herein relate to various hybrid phononic-photonic waveguide structures that can exhibit nonlinear behavior associated with traveling-wave forward stimulated Brillouin scattering (forward-SBS). The various structures can simultaneously guide photons and phonons in a suspended membrane. By utilizing a suspended membrane, a substrate pathway can be eliminated for loss of phonons that suppresses SBS in conventional silicon-on-insulator (SOI) waveguides. Consequently, forward-SBS nonlinear susceptibilities are achievable at about 3000 times greater than achievable with a conventional waveguide system. Owing to the strong phonon-photon coupling achievable with the various embodiments, potential application for the various embodiments presented herein cover a range of radiofrequency (RF) and photonic signal processing applications. Further, the various embodiments presented herein are applicable to applications operating over a wide bandwidth, e.g. 100 MHz to 50 GHz or more.

Abstract: An image cropping technique includes detecting, at a computer system including one or more processors, faces within an image and evaluating, at the computer system, the faces to determine if any of the faces correspond to people within a user's online social network. The technique additionally includes defining, at the computer system, a first crop region including a subset of the faces when at least one face within the subset of the faces corresponds to a first person in the user's online social network and cropping, at the computer system, the image based on the first crop region.

Abstract: The resonant frequency of an optical micro-resonator may be controlled by “locking” an operating frequency/wavelength of the resonator using CMOS compatible electronic components.

Abstract: The invention relates to compositions intended for reducing, ideally for eliminating, regurgitation and/or gastro-oesophageal reflux phenomena affecting a subject. Anti-regurgitation and/or anti-reflux infant formulas and milks intended for feeding newborn babies, infants and young children are more particularly described.

Abstract: The invention relates to compositions intended for reducing, ideally for eliminating, regurgitation and/or gastro-oesophageal reflux phenomena affecting a subject. Anti-regurgitation and/or anti-reflux infant formulas and milks intended for feeding newborn babies, infants and young children are more particularly described.

Abstract: An image cropping technique includes detecting, at a computer system including one or more processors, faces within an image and evaluating, at the computer system, the faces to determine if any of the faces correspond to people within a user's online social network. The technique additionally includes defining, at the computer system, a first crop region including a subset of the faces when at least one face within the subset of the faces corresponds to a first person in the user's online social network and cropping, at the computer system, the image based on the first crop region.

Abstract: The present invention relates to antibodies or fragments thereof that bind to TL1A. More specifically, the present invention relates to an antibody or fragment thereof that binds to TL1A comprising a heavy chain CDR1 comprising the amino acid sequence of SEQ ID NO: 51, and/or a heavy chain CDR2 comprising the amino acid sequence of SEQ ID NO: 52, and/or a heavy chain CDR3 comprising the amino acid sequence of SEQ ID NO: 53; and/or comprising a light chain CDR1 comprising the amino acid sequence of SEQ ID NO: 54, and/or a light chain CDR2 comprising the amino acid sequence of SEQ ID NO: 55 and/or a light chain CDR3 comprising the amino acid sequence of SEQ ID NO: 56.

Abstract: The present invention relates to antagonist antibodies or fragments thereof that bind to human OX40. More specifically, the present invention relates to an antagonist antibody or fragment thereof that binds to human OX40 comprising a heavy chain CDR1 comprising the amino acid sequence of SEQ ID NO: 1, and/or a heavy chain CDR2 comprising the amino acid sequence of SEQ ID NO: 2, and/or a heavy chain CDR3 comprising the amino acid sequence of SEQ ID NO: 3; and/or comprising a light chain CDR1 comprising the amino acid sequence of SEQ ID NO: 4, and/or a light chain CDR2 comprising the amino acid sequence of SEQ ID NO: 5 and/or a light chain CDR3 comprising the amino acid sequence of SEQ ID NO: 6.

Abstract: The present invention relates to antagonist antibodies or fragments thereof that bind to human OX40. More specifically, the present invention relates to an antagonist antibody or fragment thereof that binds to human OX40 comprising a heavy chain CDR1 comprising the amino acid sequence of SEQ ID NO: 1, and/or a heavy chain CDR2 comprising the amino acid sequence of SEQ ID NO: 2, and/or a heavy chain CDR3 comprising the amino acid sequence of SEQ ID NO: 3; and/or comprising a light chain CDR1 comprising the amino acid sequence of SEQ ID NO: 4, and/or a light chain CDR2 comprising the amino acid sequence of SEQ ID NO: 5 and/or a light chain CDR3 comprising the amino acid sequence of SEQ ID NO: 6.

Abstract: The invention relates to compositions intended for reducing, ideally for eliminating, regurgitation and/or gastro-oesophageal reflux phenomena affecting a subject. Anti-regurgitation and/or anti-reflux infant formulas and milks intended for feeding newborn babies, infants and young children are more particularly described.

Abstract: The present invention relates to antagonist antibodies or fragments thereof that bind to human OX40. More specifically, the present invention relates to an antagonist antibody or fragment thereof that binds to human OX40 comprising a heavy chain CDR1 comprising the amino acid sequence of SEQ ID NO: 1, and/or a heavy chain CDR2 comprising the amino acid sequence of SEQ ID NO: 2, and/or a heavy chain CDR3 comprising the amino acid sequence of SEQ ID NO: 3; and/or comprising a light chain CDR1 comprising the amino acid sequence of SEQ ID NO: 4, and/or a light chain CDR2 comprising the amino acid sequence of SEQ ID NO: 5 and/or a light chain CDR3 comprising the amino acid sequence of SEQ ID NO: 6.

Abstract: A front plane laminate useful in the manufacture of electro-optic displays comprises, in order, a light-transmissive electrically-conductive layer, a layer of an electro-optic medium in electrical contact with the electrically-conductive layer, an adhesive layer and a release sheet. This front plane laminate can be prepared as a continuous web, cut to size, the release sheet removed and the laminate laminated to a backplane to form a display. Methods for providing conductive vias through the electro-optic medium and for testing the front plane laminate are also described.